Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Repligen Corporation - SIC # 3840 -
Ticker
Exchange
SIC #
Website
Latest Ticker
RGEN
Nasdaq
3840
www.repligen.com
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Repligen Corporation
Wall Street Analysts Believe Repligen (RGEN) Could Rally 25.72%: Here's is How to Trade
- Jul 30th, 2026 7:55 am
Repligen Beats Q2 Earnings Estimates, Raises 2026 View, Stock Up
- Jul 29th, 2026 10:23 am
Why Repligen (RGEN) Stock Is Up Today
- Jul 29th, 2026 2:21 am
Repligen (RGEN) Held An M&A Call With BioLife Solutions.
- Jul 28th, 2026 2:12 pm
Repligen Corp (RGEN) Q2 2026 Earnings Call Highlights: Strong Growth and Raised Guidance Amidst ...
- Jul 28th, 2026 1:01 pm
Repligen Q2 Earnings Call Highlights
- Jul 28th, 2026 9:04 am
Repligen Reports Q2 Revenue Growth and Raises Full-Year 2026 Guidance
- Jul 28th, 2026 8:05 am
Repligen (RGEN) Beats Q2 Earnings and Revenue Estimates
- Jul 28th, 2026 6:15 am
Repligen (NASDAQ:RGEN) Posts Better-Than-Expected Sales In Q2 CY2026
- Jul 28th, 2026 5:22 am
Repligen Reports Second Quarter 2026 Financial Results and Updates Full Year 2026 Financial Guidance
- Jul 28th, 2026 5:00 am
Repligen (RGEN) Q2 Earnings: What To Expect
- Jul 27th, 2026 1:17 am
Hims & Hers Health, Repligen, West Pharmaceutical Services, and 10x Genomics Stocks Trade Down, What You Need To Know
- Jul 24th, 2026 4:49 pm
3 Cash-Producing Stocks That Concern Us
- Jul 24th, 2026 4:25 am
Repligen to Expand Cell Therapy Capabilities With BioLife Buyout
- Jul 23rd, 2026 9:36 am
Sector Update: Healthcare Stocks Softer Late Afternoon
- Jul 22nd, 2026 1:48 pm
Repligen to Buy BioLife Solutions for $1.5 Billion, Expanding Cell Therapy Reach
- Jul 22nd, 2026 1:03 pm
Top Midday Stories: Trump Threatens Retaliation for Attacks in Strait of Hormuz; AMD to Supply MI450 GPUs to Anthropic
- Jul 22nd, 2026 9:52 am
Repligen to Acquire BioLife Solutions, Expanding Its Cell Therapy Capabilities with Market Leading Biopreservation Media
- Jul 22nd, 2026 4:00 am
Why Repligen (RGEN) Stock Is Trading Lower Today
- Jul 21st, 2026 1:02 pm
Repligen (RGEN) Stock Looks Fairly Valued On Cash Flow But Fully Priced On Sales
- Jul 16th, 2026 7:12 pm
Scroll